Jeffrey Venstrom, MD


Jeffrey Venstrom, MD is Senior Vice President of Medical Affairs and Chief Medical Officer at GRAIL. Previously, he served as Chief Medical Partner, Cross-Portfolio (Oncology, Neurology) at Roche. Prior to that, he was Senior Vice President, Head of Clinical Development, and Medical Affairs at Foundation Medicine. Jeffrey also established and led the Hematology Biomarker Franchise at Genentech. He was also Krishnamurthi Endowed Chair in Hematologic Malignancies at The University of California – San Francisco. Jeff completed Hematology and Oncology clinical and post-graduate research training at Memorial

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2023 HLTH, INC. All Rights Reserved